Alpha Tau Medical (DRTS) Invested Capital (2020 - 2025)

Alpha Tau Medical has disclosed Invested Capital across 6 years of filings, most recently posting $77.1 million for Q4 2025.

• Invested Capital for Q4 2025 came in at $77.1 million, up 23.03% year-over-year; the trailing twelve-month figure through Dec 2025 was $77.1 million (up 23.03% YoY), and the FY2025 annual result was $77.1 million, up 23.03% from the prior year.
• Invested Capital came in at $77.1 million for Q4 2025 at Alpha Tau Medical, up from $62.7 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $108.3 million in Q2 2022 to a low of -$34.8 million in Q4 2021.
• The 5-year median for Invested Capital is $89.2 million (2022), against an average of $75.6 million.
• Across the five-year window, Invested Capital sank 312.59% in 2021 and jumped 403.81% in 2022, its largest moves.
• Alpha Tau Medical's Invested Capital stood at -$34.8 million in 2021, then surged by 403.81% to $105.7 million in 2022, then decreased by 20.05% to $84.5 million in 2023, then fell by 25.82% to $62.7 million in 2024, then advanced by 23.03% to $77.1 million in 2025.
• The last three Invested Capital figures came in at $77.1 million (Q4 2025), $62.7 million (Q4 2024), and $84.5 million (Q4 2023), per Business Quant data.